|Project Title||The Risk of Febrile Seizures following Influenza and 13-Valent Pneumococcal Conjugate Vaccines|
Evidence on the risk of febrile seizures after inactivated influenza vaccine (IIV) and 13-valent pneumococcal conjugate vaccine (PCV13) is mixed. In the FDA-sponsored Sentinel Initiative, we examined risk of febrile seizures after IIV and PCV13 in children 6-23 months of age during the 2013-14 and 2014-15 influenza seasons.
Thursday, February 13, 2020
Publications and Presentations
- Vaccines, Blood & Biologics
- Devices and Radiologic Health